Pathogen Reduction/Inactivation of Products for the Treatment of Bleeding Disorders: What Are the Processes and What Should We Say to Patients?

Annals of Hematology - Germany
doi 10.1007/s00277-017-3028-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

What We Say and How We Say It…

Journal of Family Planning and Reproductive Health Care
2004English

Mild Bleeding Disorders: What Every Clinician Should Know

British journal of hospital medicine (London, England : 2005)
Medicine
2017English

Pitheciid Vocal Communication: What Can We Say About What They Are Saying?

Ethnobiology and Conservation
Animal ScienceEcologyNatureAnthropologyZoologyPlant ScienceLandscape Conservation
2017English

Must We Know What We Say?

The Philosophical Review
Philosophy
2005English

A Review of Recent Data in the Treatment of Gallbladder Cancer: What We Know, What We Do, and What Should Be Done

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2014English

We Are What We Collect, We Collect What We Are: Archives and the Construction of Identity

American Archivist
ArtsInformation SciencesLibraryHumanities
2000English

What Patients Say, What Doctors Hear

Family Medicine
Family Practice
2018English

The Industry Premium: What We Know and What the New Zealand Data Say

New Zealand Economic Papers
EconomicsEconometricsFinance
2001English

Atherosclerosis and Lupus: What We Know and What We Should Know

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy